Advertisement

BMC Genomics

, 20:28 | Cite as

Phenotypic plasticity and the evolution of azole resistance in Aspergillus fumigatus; an expression profile of clinical isolates upon exposure to itraconazole

  • Margriet W. J. HokkenEmail author
  • Jan Zoll
  • Jordy P. M. Coolen
  • Bas J. Zwaan
  • Paul E. Verweij
  • Willem J. G. Melchers
Open Access
Research article
Part of the following topical collections:
  1. Eukaryote microbial genomics

Abstract

Background

The prevalence of azole resistance in clinical and environmental Aspergillus fumigatus isolates is rising over the past decades, but the molecular basis of the development of antifungal drug resistance is not well understood. This study focuses on the role of phenotypic plasticity in the evolution of azole resistance in A. fumigatus. When A. fumigatus is challenged with a new stressful environment, phenotypic plasticity may allow A. fumigatus to adjust their physiology to still enable growth and reproduction, therefore allowing the establishment of genetic adaptations through natural selection on the available variation in the mutational and recombinational gene pool. To investigate these short-term physiological adaptations, we conducted time series transcriptome analyses on three clinical A. fumigatus isolates, during incubation with itraconazole.

Results

After analysis of expression patterns, we identified 3955, 3430, 1207, and 1101 differentially expressed genes (DEGs), after 30, 60, 120 and 240 min of incubation with itraconazole, respectively. We explored the general functions in these gene groups and we identified 186 genes that were differentially expressed during the whole time series. Additionally, we investigated expression patterns of potential novel drug-efflux transporters, genes involved in ergosterol and phospholipid biosynthesis, and the known MAPK proteins of A. fumigatus.

Conclusions

Our data suggests that A. fumigatus adjusts its transcriptome quickly within 60 min of exposure to itraconazole. Further investigation of these short-term adaptive phenotypic plasticity mechanisms might enable us to understand how the direct response of A. fumigatus to itraconazole promotes survival of the fungus in the patient, before any “hard-wired” genetic mutations arise.

Keywords

Aspergillus fumigatus Azole resistance Phenotypic plasticity Itraconazole RNA-seq 

Abbreviations

DEGs

Differentially expressed genes

GO

Gene ontology

HOG

High osmolarity glycerol

log2FC

Log2 fold change

MAPK

Mitogen activated protein kinase

PCA

Principal component analysis

PE

Phosphatidylethanolamine

PP

Phenotypic plasticity

qRT-PCR

Quantitative real time PCR

Background

Aspergillus fumigatus is an ubiquitous fungus that plays an important role in carbon and nitrogen recycling in nature by degradation of organic biomass. It can be found in many terrestrial habitats, including soil and decaying organic matter [1]. A well-known example is the compost pile, which is considered a harsh environment as large numbers of microbes compete for nutrients, oxygen and space [2]. Various biological characteristics allow A. fumigatus to thrive in this environment, including rapid and efficient germination, tolerance for elevated temperatures, and a metabolism that is responsive to variation in nutrient sources [3, 4]. Furthermore, A. fumigatus propagates via asexual conidia that can be dispersed over wide geographic distances by air currents, and that can germinate to grow under a broad range of environmental conditions [5]. To survive and thrive, Aspergillus needs to rapidly adapt to these often challenging environments.

The remarkable ability of A. fumigatus to grow in diverse environments, contributes to its role as the predominant fungal pathogen of immunocompromised patients. As a result, Aspergillus infections are increasingly recognized as a global health problem. In humans, several diseases may be caused by A. fumigatus, ranging from allergic conditions to acute invasive aspergillosis [5, 6]. Azole antifungals are the primary choice for prevention and treatment of Aspergillus infections. Azoles inhibit the 14-α demethylase Cyp51A, as they function as a ligand of the heme group and interact with the protein structure through the azole drug side chains [7]. The inhibition of Cyp51A results in accumulation of toxic sterols, destabilisation of the plasma membrane and subsequent cell death [8]. However, A. fumigatus is able to adapt to the presence of azoles, which facilitates persistence of the species and compromises treatment options in the clinic [9].

Adaptation can be defined as the acquisition of adaptive traits through natural selection, which enables the organism to adjust to life in the prevailing or new environment [10]. Before natural selection occurs, the organism quickly adapts to a new environment by exerting its phenotypic plasticity (PP). PP allows organisms to adjust their physiology to adapt to a new and challenging environment, to still be able to maintain growth and reproduction [11, 12]. These adaptations precede the development of genetic changes and the resulting newly acquired traits. In filamentous fungi, these traits often arise by spontaneous mutation and subsequent selection if the new genotype has achieved a higher overall fitness through its phenotypic traits. Crucially, in A. fumigatus, this process has led to the development of azole resistance [13, 14, 15, 16]. Azole resistant strains have emerged in patients with aspergilloma or chronic pulmonary aspergillosis during azole therapy, but also in for instance organic-waste that contained azole residues. Azole compounds are widely used for various applications including food production, plant protection, and material preservation [17]. Thus, any environment that contains azole compounds can result in azole resistance development in A. fumigatus, provided that the fungus can complete its life-cycle [15, 18, 19]. As the dominant mechanism of resistance (TR34/L98H) is suggested to have originated in the environment, various studies have focused on the role of azole use in agriculture in the development of azole-resistant isolates [20, 21, 22].

Previously, a lot of research focused on elucidating the genetic basis of azole resistance. The most common mechanisms of resistance in A. fumigatus are modifications in the cyp51A gene. Various non-synonymous mutations in this gene have been correlated to azole resistance [13, 23, 24, 25]. These mutations cause structural changes in the conserved active site, preventing azoles from binding to the enzyme [23]. It is not well understood how the fungus maintains fitness before these mutations arise, and knowledge of the molecular basis of this development is needed in order to assess the impact of this phenomenon.

To understand the development of resistance, we previously investigated whether genetic substitutions could be induced during exposure to azoles under laboratory conditions [9, 26]. Wild type A. fumigatus isolates were exposed to both medical and environmental azoles, or a mixture of these compounds. The induction experiments generally resulted in a resistant phenotype already within three passages. However, genetic alterations were only found after at least five passages. In three out of 12 clones of A. fumigatus cultured under itraconazole pressure, cyp51A-substitutions G138C or P216L were detected. These substitutions have been reported in patients who developed azole-resistant Aspergillus disease during itraconazole therapy [24, 25].

It is not well understood how the fungus maintains fitness before these mutations arise, and thus current knowledge suggests that adaptation follows a two-step process. Firstly, patient- and environmentally acquired resistance both require an actively reproducing fungus even when exposed to azole compounds. Therefore, PP adjusts the physiology of A. fumigatus to maintain growth and reproduction at least to some extent [27]. Secondly, after these physiological adjustments, the process of natural selection maintains the mutations from the gene pool that confer genetic resistance in the azole-containing environment. Clearly, it is important to understand the adaptation strategies of A. fumigatus in relation to azole resistance selection and the clinical implications thereof for management of Aspergillus diseases.

The capability of A. fumigatus to adapt in the human host or in the outside environment is an important fungal property, which contributes to treatment failure and to the increased numbers of resistant A. fumigatus found worldwide. Therefore, this report focuses on the role of PP in the evolution of azole resistance. For A. fumigatus, this plasticity may involve, for instance, increased efflux pump activity, the activation of several stress-response pathways, or altering its lipid metabolism as ergosterol depletion affects membrane homeostasis [28, 29, 30, 31]. However, research is lacking on the cellular events that take place in the fungus directly after introduction of an antifungal compound to the environment. Furthermore, it is not known how the plasticity of the fungal physiology facilitates the selection of mutations. The early response is crucial, as the fungus needs to retain its metabolism and preferably its reproductive capability. In this study, the differential expression of the A. fumigatus genome was measured at various time points, directly after addition of itraconazole to the medium. The results provided important details on the initial transcriptional dynamics, and gave insights into membrane transporter activity, lipid metabolism, and MAPK cascade proteins, implicated to be involved in the process of phenotypic plasticity. These insights will allow us to find leads for targeted interventions.

Results

We conducted an in vitro assay in which we exposed 24 h old mycelia of clinical A. fumigatus isolates grown at 37 °C, to sublethal concentrations of itraconazole which might permit gradual adaptation of the fungus to the new, stressful environment (Table 1). Strains 130–14, 147–03 and 155–40 were grown with 0.32 μl/mL, 0.15 μl/mL and 0.13 μl/mL respectively, corresponding to the IC50 concentrations for each strain which were determined by determining the dose-response curve for each strain (Additional file 1: Figure S1). Mycelia were then harvested after 30, 60, 120 or 240 min respectively, and relative expression was compared to the mycelia harvested directly after 24 h without the addition of itraconazole.
Table 1

Three clinical A. fumigatus isolates used for transcriptomic analysis in this study. The minimum inhibitory concentration (MIC) was determined for itraconazole (ICZ), voriconazole (VCZ) and posaconazole (PCZ)

 

MIC (mg/liter)

Isolate

Date of isolation

ITZ

VCZ

PCZ

130–14

25/11/2011

1

1

0.25

147–03

25/03/2013

0.5

1

0.25

155–40

23/10/2013

1

1

0.25

Analysis of differentially expressed genes

A total of 401,706,537 sequence reads were obtained, with an average unique mapping percentage of 86.5% to the reference genome Af297 [32] (Additional file 2: Table S1). This implies that these isolates contain genomic sequences that are not present in the reference genome and thus cannot be mapped. Principle component analysis (PCA) revealed that the highest variation between samples was observed between the time points and that the replicates clustered together (Additional file 3: Figure S2). The samples of isolates 130–14 and 147–03 clustered together. The greatest amount of variation was found between the samples measured after 30 min and those measured after 240 min for isolate 130–14, or those measured after 0 min for isolate 147–03. The samples of isolate 155–40 were further removed from the other two isolates, although they show a similar pattern over time which could indicate a different basal expression level of this isolate. After comparing the gene expression between the samples taken without the addition of itraconazole (t = 0) and the samples incubated with itraconazole at the different time points, we identified 3955, 3430, 1207 and 1101 differentially expressed genes (DEGs) from a total of 9840 genes (Genome inventory, AF293 genome, AspGD, April 12, 2018) after 30, 60, 120 and 240 min of incubation with itraconazole respectively (Fig. 1). A volcano plot for each time point was created to assess the distribution of the log2FC values relative to the corrected p-value (Fig. 2).
Fig. 1

Graph representing the total numbers of differentially expressed genes after 30 min (3955 genes), 60 min (3430 genes), 120 min (1207 genes) and 240 min (1101 genes)

Fig. 2

Volcano plots of the differentially expressed genes at all time points. For each gene, the log2FC value was plotted against its respective test P-value. The red line running parallel to the x-axis indicates the statistical cutoff (P < 0.05), whereas the red line running parallel to the y-axis indicates the biological cutoff (log2FC < − 1 or > 1). Note that the y-axis displays a variable –log10(adjusted p-value), as the number of significant genes decreases over time

Verification of RNA-seq data by qRT-PCR

To check the quality of our RNA-seq dataset, we verified the expression of eight differentially expressed genes (DEGs) over a range of fold changes by conducting quantitative real time PCR (qRT-PCR) experiments. Genes were selected from different categories: up-regulated, down-regulated or non-regulated. Patterns of the RNA-seq analysis were highly similar to the patterns obtained from the qRT-PCR assays, confirming that our sequencing results were reliable (Additional file 4: Figure S3).

Functional characterization of DEGs

To investigate whether itraconazole-responsive genes could be functionally categorized, Gene Ontology (GO) enrichment analysis was performed using the AspGD GO term finder. After removal of general (e.g. ‘biological process’, ‘metabolic process’) and redundant categories with REVIGO [33], the most enriched terms from the categories Biological Process, Molecular Function and Cellular Component, were selected respectively. GO term analysis was performed for both the up-regulated and down-regulated genes [34] (Fig. 3). In general, after 30 min of incubation with itraconazole, the overall results showed a large group of enriched categories in the up-regulated genes and a small group of enriched categories of down-regulated genes. After 240 min, these numbers were reversed; a large group of enriched categories in the down-regulated genes and a small group of enriched categories was found in the up-regulated genes. Overall, no enriched terms were found in the up-regulated genes after 120 and 240 min.
Fig. 3

Heatmap of the most significant GO terms in the categories biological process, molecular function and cellular component. Highly redundant terms were removed with REVIGO. GO term enrichment was performed for the significant up- and down-regulated genes separately, for each time point. The colors represent the corrected p-value of each term

Of the 30 most enriched GO-terms in the Biological process category, the terms ‘ribosome biogenesis’, ‘ncRNA metabolic process’, ‘gene expression’ and ‘RNA processing’ were most significant in the up-regulated genes after 30 min, and in the down-regulated genes after 240 min. In addition, most enriched processes in the up-regulated genes were related to amino acid metabolism, nucleic acid metabolism, transcription, translation and general transport of RNA and proteins. The only processes enriched in the down-regulated genes after 30 and 60 min were ‘fatty acid biosynthetic process’, ‘interspecies interaction between organisms’ and ‘oxidation-reduction process’. These results indicate a decreased production of fatty acids during the first 60 min. Furthermore, the enrichment of ‘interspecies interaction between organisms’ indicates a decreased expression of genes involved in, for instance, host interaction.

After 240 min, many terms were enriched in the down-regulated genes, including ‘response to drug’ and ‘response to chemical’, indicating that transcription of genes that was altered as a response to the addition of itraconazole, is especially important during the first 2 h of incubation.

In the category Molecular Function, the term ‘drug binding’ was enriched in the up-regulated genes after 30 min and enriched in the down-regulated genes after 240 min, indicating the increase of gene products that bind specifically to a drug during the first 30 min. Furthermore, ‘unfolded protein binding’, was enriched in the down-regulated genes after 240 min. This term mainly refers to binding unfolded ER proteins, indicating a possible increase of incorrectly folded proteins that activate an ER-stress response.

In the Component category, various terms specifically referred to adjustments to the exterior of the cell. As itraconazole disturbs ergosterol biosynthesis, it is likely that membrane integrity is impaired. Interestingly, the cell adjusts various transcriptional processes related to the plasma membrane and the fungal cell wall, as a response to itraconazole. The GO term ‘plasma membrane’ was the only enriched term after 30 min in the down-regulated genes. After 60 min, the term ‘cell periphery’ was also enriched in the down-regulated genes, and the terms ‘hyphal cell wall’ and ‘cell surface’ were enriched in the down-regulated genes after 240 min.

DEGs during all time points

As the majority of all genes is differentially expressed only transiently, it would be valuable to assess whether certain genes would be differentially expressed during the whole time course, indicating an important role for these genes in the transcriptional response to itraconazole.

We investigated all genes that were differentially expressed during all time points, and a core group of 186 genes was identified (Fig. 4). Down-regulated genes included for instance; the bZIP transcription factor Yap1 (Afu6g09930), the sensor histidine kinase Fos-1/TcsA (Afu6g10240), the major allergen Aspf2 (Afu4g09580), and the putative calcineurin binding protein CbpA (Afu2g13060). Amongst the constant up-regulated genes were the putative sterol 14α demethylase Erg6 (Afu4g03630) and the fatty acid oxygenase PpoA (Afu4g10770).
Fig. 4

Venn diagram showing the overlap between the differentially expressed genes on each time point. A core set of 186 genes was differentially expressed during all time points

Furthermore, nine transcription factors, three RING finger proteins, five heat shock proteins, six MFS transporters and 26 hypothetical proteins with no current known function were identified.

A complete overview of all differentially expressed core group genes is shown in Additional file 5: Table S2.

Analysis of the top DEGs

We investigated which individual genes have the highest changes in gene expression, to assess which genes play an important role in the physical response to the addition of itraconazole to the cell. Figure 5 shows a heatmap of the 20 top up-regulated and 20 top down-regulated genes. Of these 40 genes, 14 genes were annotated as ‘hypothetical protein’ or ‘conserved hypothetical protein’. The putative elastase-inhibitor aeiA (Afu3g14940) showed the most down-regulation after 60 min. Furthermore, three putative transcription factors; ‘fungal specific transcription factor’ Afu3g14600, ‘AflR-like C6 transcription factor’ Afu2g15340 and C6 transcription factor Afu4g14590 were strongly down-regulated after 30 to 60 min. Among the 20 most up-regulated genes, the ‘short-chain dehydrogenase/reductase protein’ Afu3g02120 was the most up-regulated after 30 min. The two putative RTA1 domain proteins Afu3g00920 and Afu3g01030 showed a strong up-regulation after 30 to 60 min. Interestingly, nscA (Afu7g00160) and nscD (Afu7g00170) which are both encoded in the nsc/fcc secondary metabolite gene cluster, were strongly up-regulated. These genes are implicated to play a role in neosartoricin and fumicycline A biosynthesis. Neosartoricin was previously identified as an immunosuppressive polyketide, and fumicycline A production was shown to be induced upon exposure to the bacterium Streptomyces rapamycinicus, although no further functions have been addressed to this compound [35, 36].
Fig. 5

Heatmap of the 40 top up-and down-regulated genes. The colors represent the Log2FC of each time point, relative to reference time point t = 0

Expression profile of genes encoding putative membrane transporters

Many studies have emphasized the important role of drug efflux transporters in drug resistance in various fungal species. These transporters can be categorized as an ATP-binding cassette transporter (ABC-transporter) or a Major Facilitator Superfamily transporter (MFS-transporter), and play an important role in fungal survival [37, 38, 39]. To investigate their role in PP a high-throughput screen is necessary. We have investigated 75 DEGs involved in or predicted to be involved in drug efflux and performed hierarchical clustering based on their expression pattern (Fig. 6). Amongst the several verified multidrug efflux transporters, mdr1 (Afu5g06070) and mdr4 (Afu1g12690) were found to be the most up-regulated during the first 30 to 60 min, additionally abcA (Afu2g15130) showed an increased expression during all time points measured. Other up-regulated verified transporters include abcB (Afu1g10390), abcC (Afu1g14330) and mfs56 (Afu1g05010). Furthermore, among the other drug-efflux transporters, 25 putative transporters in three different clusters indicated by a black sidebar, showed a significant up-regulation and a similar pattern to the known drug-efflux transporters. These transporters are implicated to play a role in drug-efflux and should be investigated.
Fig. 6

Heatmap showing the hierarchical clustering of the expression patterns of all transporters predicted to play a role in drug-efflux in A. fumigatus. The colors represent the Log2FC of each time point, relative to reference time point t = 0. Euclidean distances were calculated and complete-linkage hierarchical clustering was performed. The four bars indicate groups that show moderate to strong up-regulation and could play an important role in itraconazole-efflux

The effect of itraconazole on membrane homeostasis

Azole compounds interfere with ergosterol biosynthesis, which is suggested to have a significant impact on membrane rigidity [40]. Therefore, we analyzed all genes involved in the ergosterol biosynthesis pathway. Additionally, we analyzed the key pathways involved in phospholipid biosynthesis; the CDP-DAG pathway and the Kennedy pathway, which are postulated to be very similar to the Saccharomyces cerevisiae pathways [41]. These pathways are involved in the production of phospholipids from phosphatidic acid de novo, and the production of phosphatidylethanolamine (PE) and phosphatidylcholine (PC) from exogenous ethanolamine and choline, respectively [42]. Therefore, they play an important role in maintaining membrane integrity and DEGs in these pathways could provide leads on how A. fumigatus exerts its phenotypic plasticity.

Differentially expressed genes in the ergosterol biosynthesis pathway

To investigate the transcriptional effects of Cyp51A inhibition in the ergosterol biosynthesis pathway, the expression profile of 30 genes involved in ergosterol biosynthesis was analyzed, including those in the mevalonate pathway (Fig. 7a). The mevalonate pathway facilitates the conversion of acetyl-CoA to farnesylpyrophosphate, the first compound utilized in the ergosterol biosynthesis pathway. The erg13A gene showed the highest down-regulation of log2FC -4.2 after 30 min, while the hydroxymethylglutaryl-CoA (HMG-CoA) reductase hmg1 was the most up-regulated. The other putative HMG-CoA reductase hmg2 showed a strong up-regulation, but was not considered significantly differentially expressed due to an average read count of 2.53 in the 30 sequenced samples.
Fig. 7

The colors represent the Log2FC of each time point, relative to reference time point t = 0. a Heatmap of all enzymes with a verified or predicted role in the mevalonate biosynthesis. b Heatmap of all enzymes with a verified or predicted role in the ergosterol biosynthesis. The erg6 gene shows strong up-regulation through the entire time series. c Mevalonate and ergosterol biosynthesis pathways in A. fumigatus

In the steroid biosynthesis pathway, an overall down-regulation of genes within 30 min was observed, including down-regulation of cyp51A and cyp51B (Fig. 7b). Out of the 20 genes, 15 genes were found to be down-regulated. The strongest up-regulation at all time points was measured at the erg6 gene, which functions directly upstream of Cyp51A and Cyp51B. The other genes that were measured to be up-regulated, were the C-8 sterol isomerase gene erg2 and the C-24 sterol reductase erg4.

Phosphatidylethanolamine biosynthetic genes show fast up-regulation after 30 min

Analysis of lipid biosynthetic genes showed mainly up-regulation of genes involved in the production of one of the major phospholipids, phosphatidylethanolamine [43] (Fig. 8). The mitochondrial phosphatidylserine decarboxylase psd1 was up-regulated log2FC 1.36 after 30 min. Furthermore, the genes involved in the production of PE from extracellular ethanolamine were up-regulated after 30 min; eki1, ect1 and ept1 showed an up-regulation of log2FC 1.49, 1.52 and 2.54, respectively. After 240 min, these genes were down-regulated. The most down-regulated genes included the C16:0-CoA desaturase ole1 with a log2FC of − 4.16, and the CDP-diacylglycerol-inositol 3-phosphatidyltransferase pis1 with a log2FC of − 2.22 after 30 min. Down-regulation of the acyl-CoA desaturase ole1 will decrease the synthesis of unsaturated fatty acids [44], increasing membrane lipid saturation. An increase in membrane lipid saturation increases membrane rigidity [45], possibly as a mechanism to compensate for the loss of rigidity due to ergosterol depletion.
Fig. 8

a Heatmap of all A. fumigatus enzymes homologous to S. cerevisiae enzymes which exert a key function in (phospho)lipid metabolism. The colors represent the Log2FC of each time point, relative to reference time point t = 0. The genes indicated by a black sidebar are orthologues to the S. cerevisiae genes responsible for de novo biosynthesis of phosphatidylethanolamine, and show a 1.5–2.4 log2FC. b Glycerolipid biosynthesis pathways in S. cerevisiae

Differential expression of MAP kinases

Previous research showed that Hsp90 and MAPK proteins are involved in the azole-induced response to membrane stress in Candida spp. [46]. To investigate which signaling pathways could be potentially involved in the physical response to itraconazole, we investigated the MAPK cascades present in A. fumigatus [31, 47]. Ten genes have been identified as potential components of three MAPK cascades in A. fumigatus (Fig. 9) [31]. The MAPKK Mkk2 (Afu1g05800) is homologous to S. cerevisiae ScMKK2, and is involved in cell wall integrity signaling and membrane fluidity sensing [48, 49]. We observed that mkk2 was down-regulated log2FC of − 1.61 after 60 min. The proteins MAPKKK SskB (Afu1g10940), MAPKK Pbs2 (Afu1g15950), MAPK SakA (Afu1g12940) and MpkC (Afu5g09100) have been identified to play a role in high osmolarity signaling [50, 51], and are considered homologs of the HOG-MAPK pathway in S. cerevisiae. The sskB gene was up-regulated log2FC 1.45 after 60 min. The MAPK proteins SakA and MpkC were up-regulated log2FC 1.26 after 60 min, and up-regulated log2FC 1.33 after 240 min, respectively. Additionally, we found that homologs of three genes involved in glycerol formation in A. nidulans were up-regulated [52, 53]. The putative glycerol-3-phosphate dehydrogenase gfdA (Afu1g02150) and the putative glycerol-3-phosphate phosphatase gppA (Afu1g10570) showed up-regulation of log2FC 1.86 and 1.24 after 30 min, respectively. The other putative glycerol-3-phosphate dehydrogenase gfdB (Afu2g08250) showed up-regulation of log2FC 1.38 after 60 min (Additional file 6: Table S3).
Fig. 9

Heatmap of all verified and putative MAP kinases in A. fumigatus. The colors represent the Log2FC of each time point, relative to reference time point t = 0. The MAPK sakA and the MAPKKK sskB show a 1.3 log2FC and a 1.5 log2FC after 60 min, respectively

Comparison with transcriptome data of several stresses

In this study, we have described the general transcriptional patterns at four time points, various categories of genes and several groups of genes in particular, in the response of A. fumigatus to itraconazole. It should be noted that many transcriptional changes measured are presumably part of a general stress response which is activated not only in response to itraconazole stress. To investigate this, all differentially expressed genes were compared with the transcriptome data of previously conducted research [47, 54]. In the study of Da Silva Ferreira et al. mycelia were exposed to voriconazole, and analyzed after 30, 60, 120 and 240 min of incubation via microarray analysis. In the study of Takahashi et al., various stress responses were induced through heat shock (37 °C and 48 °C), osmotic stress, and superoxide stress, and the transcriptomic changes were monitored through RNA-seq at 15, 30, 60, 120 and 180 min after induction. The genes were selected based on the cutoff values log2FC > 1 or < − 1, and DEGs at all time points were combined. DEGs from both heat shock treatments were also combined. A Venn diagram overlapping these genes was generated, (Fig. 10, Additional file 7: Table S4). A group of 257 genes was identified uniquely to be differentially expressed upon exposure to itraconazole (Additional file 8: Table S5). Of these 257 unique genes, five genes were merged due to complex annotation changes. The most up-regulated gene during all time points with a log2FC 2.7 to 10.7 has predicted oxidoreductase activity and a role in metabolic process (Afu3g02120). The most down-regulated gene after 30 min with a log2FC of − 7.6 has predicted oxidoreductase activity and a role in an oxidation-reduction process (Afu4g00560). The most down-regulated gene after 60, 120 and 240 min with a log2FC of − 4.1 to − 6.1 has predicted coenzyme binding and oxidoreductase activity (Afu5g01250). Several other down-regulated genes in this group are the O-methyltransferase tpcA (Afu4g14580), the putative alpha-amylase amyA (Afu3g00900), and the essential 1,3-beta-glucanosyltransferase gel4 (Afu2g05340). Additionally, the putative C-5 sterol desaturase erg3C (Afu8g01070), the putative sterol sensing factor insA (Afu4g07680), and an ortholog of a gene which exhibits intermembrane sterol transfer activity in S. cerevisiae (Afu5g07100), are down-regulated. The up-regulated genes contain the allergen aspf28 (Afu6g10300), the parvulin-like peptidyl-prolyl cis-trans isomerase par1 (Afu1g05450), and the cbkA gene (Afu1g09950) which is regulated by the crzA transcription factor in A. fumigatus [55].
Fig. 10

Itraconazole responsive genes. Venn diagram comparing all DEGs of this study and the DEGs found by da Silva Ferreira et al., and Takahashi et al., after exposing A. fumigatus to different stresses to compare transcriptional responses. After removal of merged genes, 251 unique DEGs remain which were only differentially expressed upon exposure to itraconazole

Discussion

The goal of this study was to investigate differential gene expression in azole-susceptible clinical strains after the addition of sub-lethal concentrations of itraconazole, to gain valuable insights into the way A. fumigatus exerts its phenotypic plasticity and manages to survive. We gained insight in the general expression patterns which take place as A. fumigatus adapts to the presence of an antifungal compound, and identified 25 potential drug-efflux transporters which potentially aid the fungus to survive by exporting itraconazole from the cell. Furthermore, we demonstrated that the erg6 gene was up-regulated during the whole time course and that the genes facilitating PE production from extracellular ethanolamine were up-regulated, indicating an increased production of this phospholipid. Finally, we observed an increased expression of several MAPK cascade proteins which are also involved in HOG signaling. This study is, to our knowledge, the first study to use RNA-seq to measure gene expression of clinical isolates in response to itraconazole.

In our experimental setup, we compared the isolates of each time point with the isolates directly harvested after 24 h. Although we do not distinguish between the transcriptional changes caused by itraconazole or other changes related to mycelial growth progression, previous research demonstrated that A. fumigatus resides in the exponential growth phase after 24 h, in various nutrient media [56]. Interpreting transcriptomics results is limited by the fact that only 487 (4.95%) genes have been experimentally verified and characterized in A. fumigatus, making the interpretation of transcriptomics results challenging (Aspergillus fumigatus Af293 Genome Snapshot, AspGD, May 14th, 2018). Although many gene functions are predicted computationally through known functions of homologous genes in other closely related species, they are yet to be experimentally confirmed. It was notable that the number of enriched GO terms per time point was not a direct consequence of the number of genes in the group; the 2254 down-regulated genes after 30 min yielded only five enriched GO terms in the category process, as opposed to the 1701 up-regulated genes after 30 min, which yielded a total of 194 enriched GO terms in the category process before the removal of redundant terms. This suggests that many cellular processes are down-regulated after 30 min, but all to similar extent as no specific terms are enriched.

GO term enrichment analysis showed increased activity of various specific processes related to the exterior of the cell, consistent with previous research that states that itraconazole decreases membrane integrity by interfering with ergosterol biosynthesis [40, 57]. The cellular component category also showed the enriched term ‘extracellular matrix’ in the up-regulated genes after 60 min, which mainly comprises of genes which are part of the fungal biofilm matrix. These biofilms are often involved in host adherence and provide protection from extracellular stresses, suggesting an important role for biofilm formation in the physiological response of A. fumigatus [58, 59].

The involvement of elastase in fungal virulence is discussed in several studies, and its contribution to pathogenicity, by breaking down elastin in lung tissue, is not well established for A. fumigatus [60, 61, 62, 63]. We found that the putative elastase inhibitor aeiA (Afu3g14940) was the most down-regulated gene in our dataset (log2FC 8.27). There is a possibility that these clinical strains have specifically adapted to the lung environment, and that there are other beneficial effects that do not influence virulence, although these results suggest that A. fumigatus greatly adjusts its elastase activity upon itraconazole stress.

Amongst the strongest up-regulated genes were two putative RTA1 domain proteins. Not much is known about this gene family, that was initially found to be involved in the export of long sphingoid bases in S. cerevisiae [64]. Interestingly, overexpression of ScRTA1 results in 7-aminocholesterol resistance, an antifungal compound that inhibits sterol biosynthesis. Heme-deficiency was also shown to induce ScRTA1 expression. It is likely that disturbance of ergosterol biosynthesis influences iron homeostasis in the fungal cell, as these processes share mevalonate as a precursor and are both regulated by the sterol regulatory element binding protein SrbA [65, 66]. When heme or iron sources are deficient, siderophore mediated iron-uptake is increased, and hmg1 expression is up-regulated. This is consistent with our finding that hmg1 expression is increased [64, 66]. The role of RTA1 proteins in the physical response to azoles has not yet been established and could provide an interesting lead.

A large number of transporters have been described in A. fumigatus, and the fungus can defend itself against a large number of toxic compounds via for instance drug-efflux pump activity [67, 68]. The genome of A. fumigatus is predicted to contain at least 49 ATP binding cassette (ABC) family transporter genes and 278 major facilitator superfamily (MFS) genes. From the AspGD website, only genes encoding transporters were extracted that were predicted to play a role in drug efflux specifically. This might leave out potential other transporter genes, which are not yet computationally predicted to be involved in drug efflux in general. Nevertheless, 25 transporters showed comparable expression patterns to the verified drug-efflux transporters within the first. These transporters could play an important role in physical resilience induced by PP, and their involvement should be addressed experimentally in future research.

We investigated to what extent itraconazole influences the expression of ergosterol biosynthetic genes. Alterations in the ergosterol biosynthesis pathway have been shown to confer resistance in a previous study with Candida albicans [69]. Strikingly, erg6 showed a significant up-regulation of log2FC 1.78–3.54 during the whole time course, as opposed to the rest of the ergosterol biosynthetic pathway, which showed a general down-regulation, or no-regulation. Recent studies suggested that not Cyp51A, but Erg6 is the 14α-lanosterol demethylase in A. fumigatus, as opposed to S. cerevisiae, where ScERG6 encodes a sterol 24-C-methyltransferase further downstream [8, 70, 71, 72]. Erg6 functions directly upstream of Cyp51A, where it first converts lanosterol to eburicol. Inhibition of Cyp51A by azoles and up-regulation of erg6 would then lead to a strong accumulation of eburicol. Why the increased production of eburicol would be a favorable trait when this compound possibly already accumulates as the Cyp51A enzyme is inhibited by azoles [8], is not clear. It is possible that a feedback regulation mechanism senses the absence of the Cyp51A/B product, 4,4,24-trimethylcholesta-8,24(28)-dien-3β-ol, when they are inhibited by azoles with the increased production of their substrate as a direct result.

The genes involved in biosynthesis of phosphatidylethanolamine (PE) from extracellular ethanolamine showed a predominant up-regulation. A recent study on mammalian cells suggests that PE is the key phospholipid in maintaining proper membrane rigidity, and they found that a decrease in cholesterol resulted in a strong increase of PE relative to the other phospholipids [73]. These genes were identified as the most up-regulated of all lipid biosynthesis genes investigated in this study and could imply an increase of PE in the membranes to maintain proper rigidity, when ergosterol levels are depleted [45, 74].

The important role of cell signaling in fungal adaptation to stress factors and antifungals has been extensively demonstrated [31, 75, 76, 77]. We have investigated the involvement of MAPK cascade proteins upon azole stress. The mpkB gene is still uncharacterized in A. fumigatus, however, the mpkB gene in A. nidulans and the FUS3 gene in S. cerevisiae are well-described homologs. Their role in the cellular pheromone response and sexual development is established [78, 79], indicating a possible role of these processes in the response to itraconazole stress. Furthermore, we measured a significant up-regulation in the sakA MAPK gene, which is homologous to the HOG1 gene of S. cerevisiae. This gene is the key MAP kinase involved in the regulatory processes in response to osmotic, oxidative, heat, and hypoxia mediated stresses [31]. In A. fumigatus, sakA has been shown to play an important role in the osmotic and oxidative stress responses. Deletion mutants showed an increased sensitivity to itraconazole and amphotericin B [80], which is consistent with our finding that sakA expression is increased as a response of A. fumigatus to itraconazole. Our results suggest that upon exposure to itraconazole, A. fumigatus differentially regulates genes which are related to the osmotic stress response and increases its glycerol production. This is supported by our findings that at least three genes involved in glycerol formation were up-regulated within 60 min. Transcriptional changes of MAP kinases could give insight into the stress-response mechanisms [47], although MAP kinases are activated by phosphorylation [81]. Therefore, analysis of the phosphoproteome could provide additional insights into their direct involvement in adaptation to itraconazole stress.

Recently, the mitochondrial complex I has been implicated to play a role in azole resistance. Interestingly, our results show only a slight down-regulation of the 29.9 KD subunit of mitochondrial complex I (Afu2g10600: Log2FC -0.81, P-value 0.01, adjusted P-value 0.07) (Additional file 7: Table S4) after 240 min, although deletion of this gene leads to partial azole resistance (80). The authors suggest a resistance mechanism based on restoring an unbalanced oxidative stress response when itraconazole (1 mg/L) is added to the medium. However, the DEGs in our dataset do not indicate an oxidative response in our isolates exposed to itraconazole, as we did not measure up-regulation of genes that are induced upon hypoxic conditions [82]. Therefore, a down-regulation of the 29.9 KD subunit would not be necessary to rebalance the oxidative stress response. It is also possible that this gene is not differentially regulated and does not contribute to PP to gain azole resilience, although further research is necessary to elucidate if higher concentrations of itraconazole could result in a different expression pattern.

Many mechanisms that cope with cell stress respond to various stressful conditions, and are not limited to a specific stress condition or a specific antifungal compound [47, 83, 84]. To investigate if A. fumigatus differentially expresses genes solely in response to itraconazole, we compared our results to the transcriptomics data of previously conducted studies [47, 54]. We found that 251 genes were differentially regulated specifically in response to itraconazole. Although genetic and physiological differences between isolates compared across different studies may influence this outcome, these results suggest that transcription of these genes is specifically altered as a response to itraconazole stress. Amongst these genes is the down-regulated insA (Afu4g07680) gene, which is a putative sterol sensing factor. The mammalian homolog encodes an ER-anchored protein which prevents the transcriptional activation of genes involved in the synthesis and uptake of cholesterol, by binding to sterol regulatory element binding proteins (SREBPs) [85]. It is possible that A. fumigatus anticipates on ergosterol deficiency by down-regulating this gene to prevent inhibition of sterol synthesis and uptake, although little is known about the sterol sensing mechanisms in A. fumigatus.

Remarkably, previous reported DEGs resulting from voriconazole treatment share but 72,6% with DEGs from our study, despite of their shared mechanism of action. These difference could be appointed to the treatment of the isolates with a higher concentration of voriconazole (0.5 μg/mL) and although the exact MIC of the tested isolates was not documented, this could explain the different DEGs found. Additionally, the isolates tested in this study demonstrated that even between different isolates that have the same MIC, the basal expression of the transcriptome can differ. Furthermore, the difference could be appointed to the comparison of microarray results with RNA-seq results, with the latter having higher resolution. Future studies could be improved by introduction of a conserved laboratory strain in every experiment, which would facilitate better comparison.

As demonstrated in this study, RNA-seq is a promising method to provide better insight in the physiological changes and cellular defense mechanisms [86, 87, 88]. Although many processes can be monitored this way, it should be taken into account that a decreased or increased transcription, does not necessarily lead to an increased translation. Additionally, post-translational processes could further impact on the suggested increased abundance of activated proteins. It is essential that potential genes or pathways involved in the cellular response to itraconazole are confirmed by the generation of gene-deletion mutants. Furthermore, it could be promising to look at the direct consequences of the various transcriptional changes related to ergosterol and lipid biosynthesis, by investigating the full lipidome of A. fumigatus mycelia under various conditions.

Conclusions

Our data strongly suggests that phenotypic plasticity allows A. fumigatus to substantially adapt its transcriptome within 60 min of exposure to itraconazole, after which the cells proposedly reach an improved homeostatic state. We showed that short-term adaptation through PP includes immediate up-regulation of several drug-efflux membrane transporters, activation of signaling cascades, and various alterations in gene expression in the ergosterol biosynthesis and phospholipid biosynthetic processes. Thus, our study supports the notion that transcriptomic analyses by RNA-seq can give major insights in the differentially expressed genes, enabling us to understand how the direct response of A. fumigatus to itraconazole promotes survival of the fungus in the patient and in the outside environment before any stable genetic mutations arise. Further research on PP and the short-term adaptation processes of A. fumigatus can improve the understanding on how the fungus survives during azole exposure. Increasing this fundamental knowledge is crucial in managing the spread of azole resistant A. fumigatus isolates and developing future antifungal therapies.

Methods

Isolates, media and culture conditions

Isolates were used with an MIC of 0.5 or 1 for itraconazole and the same MIC for voriconazole and posaconazole respectively, to exclude the possibility that great differences in outcome could be assigned to the differences in MICs for these isolates. The isolates were selected from three different patients from separate hospitals in the Netherlands. All isolates are listed in Table 1. Isolates were cultured on either Sabouraud Dextrose Agar (SDA) (Oxoid) (1% peptone, 4% glucose, 1.5% agar, pH 5.6) or Aspergillus Minimal Medium (AMM) as described in the supplemental material of reference [89] containing per liter: 10 g glucose, 5.95 g NaNO3, 0.522 g KCl, 1.5 g KH2PO4, 50 mg MgSO4·7H2O, 1 mL trace elements). Trace elements contained (per 200 mL): 10 g EDTA, 4.4 g ZnSO4·7H2O, 1.01 g MnCl2·4H2O, 0.315 g CuSO4·5H2O, 0.22 g (NH4)6Mo7O24·4H2O, 1.0 g Fe(II)SO4·7H2O, and 2.2 g H3BO3 [90]. All compounds were produced by Merck (Darmstadt, Germany). Isolates were stored in 20% glycerol at − 80 °C, and subcultured on SDA at 37 °C for 4–5 days. Conidia were harvested with a wet cotton swab and resuspended in Milli-Q containing 0.1% Tween 20. Approximately 2,6 × 105 CFU/mL of conidia were used to inoculate 5 mL of AMM in 15 mL tubes. Conidia were inoculated in duplicate. After 24 h of growth at 37 °C while rotating, itraconazole (Sigma) was added at IC50 to each tube except the T = 0 tubes, which were immediately harvested through Miracloth (Merck). Remaining mycelia were harvested through Miracloth after 30, 60, 120 and 240 min. Harvested mycelia were directly frozen in liquid nitrogen.

Dose-response curves

For determining the itraconazole concentration where growth is estimated to be 50% (IC50), dose-response curves were made by growing each strain (n = 5) in a 96-wells plate containing AMM with itraconazole concentrations ranging from 0.016 μg/mL to 8 μg/mL. Plates were kept at 37 °C in a microtiter plate reader (Anthos Labtec Instruments GmbH, Salzburg, Austria) for 48 h, and optical density (OD) was measured every hour at 405 nm. After subtraction of the ODs of the empty wells, the percentage of growth from the ODs of the inoculated wells for each well was correlated with the relative OD estimated by the following equation: (OD405 of wells that contained itraconazole/OD405 of the itraconazole-free well) × 100. The relationship was determined by a non-linear regression analysis and the Hill equation with a variable slope fitted to the data. Goodness of fit was checked by the r2 values. All analyses were performed by using GraphPad Prism, version 6.0, for OS X (GraphPad Software, San Diego, USA).

RNA sequencing

After harvesting, mycelia were lysed by bead-bashing using a MagNa Lyser instrument, three times for 30 s at 7000 rpm (Roche, Basel, Switzerland). RNA was extracted using TRIzol reagent (Invitrogen, Breda, the Netherlands). Pellets were resuspended in 100 μL DEPC treated water. RNA integrity was verified by agarose gel electrophoresis. Total RNA was stained with Midori Green (Nippon Genetics, Dueren, Germany) and visualized with UV light. Purity of all samples (A260/A280 ≥ 1.5 and A260/A230 ≥ 2.0) was determined using a NanoDrop 1000 (Thermo Scientific, MA, US). Pooled cDNA libraries were constructed with the TruSeq RNA Sample Prep Kit v2 (Illumina, San Diego, USA) according to manufacturer instructions. Quality of the libraries was verified with an Agilent 4200 Tapestation System (Agilent Technologies). Paired-end reads of 2 × 75 bp were generated in High Output mode on a NextSeq 500 sequencer (Illumina, San Diego, USA).

Identification of differentially expressed genes

Reads were aligned with STAR v2.5.3A [91] against the reference genome sequence of A. fumigatus Ensemble CADRE 30 downloaded from EnsemblFungi. Differentially expressed genes (DEGs) were identified by DESeq2 for R by Bioconductor (BaseMean ≥30, P-value < 0.05, adjusted P-value < 0.1, log2FC > 1 or < − 1), and results were corrected for multiple testing by the Benjamini-Hochberg principle [92].

GO analysis

Functional categories of DEGs were grouped according to the Gene Ontology (GO) term, using the GO Term Finder on the AspGD website to identify significant terms (p ≤ 0.05) [93]. The False Discovery Rate cutoff value was set to p ≤ 0.05. REVIGO was used to remove redundant GO terms [33] and allowed similarity was set to 0.5. Terms with over 30% frequency were removed to avoid general terms. Up-regulated and Down-regulated genes were screened separately for enriched categories, to improve statistical power [34].

Validation of RNA-seq results by quantitative real-time PCR

All primers are listed in Additional file 9: Table S6. Eight genes with different expression patterns were selected, and expression was confirmed in all three strains separately. RNA isolation and cDNA synthesis were performed as described above. Quantitative real-time PCR was performed with gene-specific primers, using the actin gene (act1) as reference gene. PCR was performed using Roche Lightcycler 480 SYBR Green I Master according to the protocol of the manufacturer. PCR conditions were as follows: Denaturation at 95 °C for 5 min, followed by 45 cycles of denaturation at 95 °C for 10 s, primer annealing at 60 °C for 10 s, and extension at 72 °C for 10 s. Expression levels were calculated by the ΔΔCT-method, and normalized for actin mRNA expression levels [94]. All qRT-PCR experiments were per-formed at least in duplicates.

Statistical analysis and figure construction

Heatmaps and volcano plots were generated by Rstudio Version 1.0.143 for OS X. For generating heatmaps, gplots v3.0.1 was used. For generating volcano plots, ggplot2 V2.2.1 was used. Exported images were assembled with Adobe Illustrator CC 2015. Venn diagrams were created with Biovenn (http://www.biovenn.nl/index.php) and the Venn tool by (http://bioinformatics.psb.ugent.be/webtools/Venn). Graphs of qRT-PCR and dose-response curve analyses were generated by using GraphPad Prism, version 6.0, for OS X (GraphPad Software, San Diego, USA). Error bars represent standard error of the mean.

Notes

Acknowledgements

We would like to thank Hein van der Lee and Marlou Tehupeiory-Kooreman for their excellent experimental support and their fungal expertise. We would also like to thank Mike Renne for valuable discussions and critical reading of the manuscript.

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Availability of data and materials

The sequences reported in this paper have been deposited in the NCBI Sequence Read Archive (SRA) database, in a BioProject under accession number PRJNA482512.

Authors’ contributions

MWJH participated in designing the research, carried out the RNA-seq, analysed data and wrote the manuscript. JZ participated in designing the research, and carried out and analysed the qRT-PCR experiments. JPMC analysed RNA-seq data. BJZ conceived the study and wrote the manuscript. PEV participated in designing the research and coordinated the study. WJGM conceived and coordinated the study, participated in designing the research and wrote the manuscript. All of the authors read and approved the final manuscript.

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary material

12864_2018_5255_MOESM1_ESM.pdf (36 kb)
Additional file 1: Figure S1. Dose-response curves of the three A. fumigatus strains upon exposure to increasing concentrations of itraconazole, ranging from 0.016 mg/l to 8 mg/l. (PDF 36 kb)
12864_2018_5255_MOESM2_ESM.docx (49 kb)
Additional file 2: Table S1. Mapping results and coverage calculations. (DOCX 79 kb)
12864_2018_5255_MOESM3_ESM.pdf (114 kb)
Additional file 3: Figure S2. PCA plot of all samples, normalized by a regularized log transformation. (PDF 113 kb)
12864_2018_5255_MOESM4_ESM.pdf (298 kb)
Additional file 4: Figure S3. The expression levels of eight selected genes, verified by RT-PCR. The values were normalized to the actin expression, and error bars represent standard deviation of the mean. (PDF 297kb)
12864_2018_5255_MOESM5_ESM.docx (80 kb)
Additional file 5: Table S2. The 186 genes found to be differentially expressed at all time points. (XLSX 59kb)
12864_2018_5255_MOESM6_ESM.xlsx (59 kb)
Additional file 6: Table S3. The DESeq2 dataset results. (XLSX 5090 kb)
12864_2018_5255_MOESM7_ESM.xlsx (5 mb)
Additional file 7: Table S4. Venn analysis results of all shared genes per group. (TXT 128 kb)
12864_2018_5255_MOESM8_ESM.xlsx (63 kb)
Additional file 8: Table S5. All 251 genes that were only differentially expressed upon itraconazole stress. (XLSX 62 kb)
12864_2018_5255_MOESM9_ESM.txt (129 kb)
Additional file 9: Table S6. All primers used in this study. (DOCX 49 kb)

References

  1. 1.
    Latgé JP. The pathobiology of Aspergillus fumigatus. Trends Microbiol. 2001;9(8):382–9.PubMedCrossRefPubMedCentralGoogle Scholar
  2. 2.
    Boulter JI, Trevors JT, Boland GJ. Microbial studies of compost: bacterial identification, and their potential for turfgrass pathogen suppression. World J Microbiol Biotechnol. 2002;18(7):661–71.CrossRefGoogle Scholar
  3. 3.
    Rhodes JC. Aspergillus fumigatus: growth and virulence. Med Mycol. 2006;44(SUPPL. 1):77–81.CrossRefGoogle Scholar
  4. 4.
    Kwon-Chung KJ, Sugui JA. Aspergillus fumigatus-what makes the species a ubiquitous human fungal pathogen? PLoS Pathog. 2013;9(12):1–4.CrossRefGoogle Scholar
  5. 5.
    Paulussen C, Hallsworth JE, Álvarez-Pérez S, Nierman WC, Hamill PG, Blain D, et al. Ecology of aspergillosis: insights into the pathogenic potency of Aspergillus fumigatus and some other Aspergillus species. Microb Biotechnol. 2017;10(2):296–322.PubMedCrossRefPubMedCentralGoogle Scholar
  6. 6.
    Latgé JP. Aspergillus fumigatus and Aspergillosis. Clin Microbiol Rev. 1999;12(2):310–50.PubMedPubMedCentralCrossRefGoogle Scholar
  7. 7.
    Warrilow AG, Parker JE, Kelly DE, Kelly SL. Azole affinity of sterol 14-Demethylase (CYP51) enzymes from Candida albicans and Homo sapiens. Antimicrob Agents Chemother. 2013;57(3):1352–60.PubMedPubMedCentralCrossRefGoogle Scholar
  8. 8.
    Dhingra S, Cramer RA. Regulation of sterol biosynthesis in the human fungal pathogen Aspergillus fumigatus: opportunities for therapeutic development. Front Microbiol. 2017;8:1–14.CrossRefGoogle Scholar
  9. 9.
    Verweij PE, Zhang J, Debets AJM, Meis JF, van de Veerdonk FL, Schoustra SE, et al. In-host adaptation and acquired triazole resistance in Aspergillus fumigatus: a dilemma for clinical management. Lancet Infect Dis. 2016;16(11):e251–60.PubMedCrossRefPubMedCentralGoogle Scholar
  10. 10.
    Lenski RE. What is adaptation by natural selection? Perspectives of an experimental microbiologist. PLoS Genet. 2017;13(4):1–12.CrossRefGoogle Scholar
  11. 11.
    Stern S, Dror T, Stolovicki E, Brenner N, Braun E. Genome-wide transcriptional plasticity underlies cellular adaptation to novel challenge. Mol Syst Biol. 2007;3(106):1–9.Google Scholar
  12. 12.
    Agrawal AA. Phenotypic plasticity in the interactions and evolution of species. Science. 2001;294(5541):321–6.Google Scholar
  13. 13.
    Snelders E, Van Der Lee HAL, Kuijpers J, Rijs AJMM, Varga J, Samson RA, et al. Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism. PLoS Med. 2008;5(11):1629–37.CrossRefGoogle Scholar
  14. 14.
    Denning DW, Venkateswarlu K, Oakley KL, Anderson MJ, Manning NJ, Stevens DA, et al. Itraconazole resistance in Aspergillus fumigatus. Antimicrob Agents Chemother. 1997;41(6):1364–8.PubMedPubMedCentralCrossRefGoogle Scholar
  15. 15.
    van der Linden JWM, Arendrup MC, Melchers WJG, Verweij PE. Azole resistance of Aspergillus fumigatus in Immunocompromised patients with invasive Aspergillosis. Emerg Infect Dis. 2016;22(1):158–9.PubMedPubMedCentralCrossRefGoogle Scholar
  16. 16.
    Zhang J, Debets AJM, Verweij PE, Melchers WJG, Zwaan BJ, Schoustra SE. Asexual sporulation facilitates adaptation: the emergence of azole resistance in Aspergillus fumigatus. Evolution (N Y). 2015;69(10):2573–86.Google Scholar
  17. 17.
    Snelders E, Camps SMT, Karawajczyk A, Schaftenaar G, Kema GHJ, van der Lee HA, et al. Triazole fungicides can induce cross-resistance to medical triazoles in Aspergillus fumigatus. PLoS One. 2012;7(3):e31801.PubMedPubMedCentralCrossRefGoogle Scholar
  18. 18.
    Buil JB, Meis JF, Melchers WJG, Verweij PE. Are the TR 46 /Y121F/T289A mutations in azole-resistant Aspergillosis patient acquired or environmental? Antimicrob Agents Chemother. 2016;60(5):3259–60.PubMedPubMedCentralCrossRefGoogle Scholar
  19. 19.
    Hollomon D. Does agricultural use of azole fungicides contribute to resistance in the human pathogen Aspergillus fumigatus? Pest Manag Sci. 2017;73(10):1987–93.PubMedCrossRefPubMedCentralGoogle Scholar
  20. 20.
    Vaezi A, Fakhim H, Javidnia J, Khodavaisy S, Abtahian Z, Vojoodi M, et al. Pesticide behavior in paddy fields and development of azole-resistant Aspergillus fumigatus: should we be concerned? J Mycol Med. 2018;28(1):59–64.PubMedCrossRefPubMedCentralGoogle Scholar
  21. 21.
    Verweij PE, Snelders E, Kema GH, Mellado E, Melchers WJ. Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use? Lancet Infect Dis. 2009;9(12):789–95.PubMedCrossRefPubMedCentralGoogle Scholar
  22. 22.
    Zhang J, Snelders E, Zwaan BJ, Schoustra SE, Meis JF, Van Dijk K, et al. A novel environmental azole resistance mutation in Aspergillus fumigatus and a possible role of sexual reproduction in its emergence. MBio. 2017;8(3):1–13.CrossRefGoogle Scholar
  23. 23.
    Snelders E, Camps SMT, Karawajczyk A, Rijs AJMM, Zoll J, Verweij PE, et al. Genotype-phenotype complexity of the TR46/Y121F/T289A cyp51A azole resistance mechanism in Aspergillus fumigatus. Fungal Genet Biol. 2015;82:129–35.PubMedCrossRefPubMedCentralGoogle Scholar
  24. 24.
    Diaz-Guerra TM, Mellado E, Cuenca-Estrella M, Rodríguez-Tudela JL. A point mutation in the 14α-sterol demethylase gene cyp51A contributes to itraconazole resistance in Aspergillus fumigatus. Antimicrob Agents Chemother. 2003;47(3):1120–5.PubMedPubMedCentralCrossRefGoogle Scholar
  25. 25.
    Mann PA, Parmegiani RM, Wei SQ, Mendrick CA, Li X, Loebenberg D, et al. Mutations in Aspergillus fumigatus resulting in reduced susceptibility to posaconazole appear to be restricted to a single amino acid in the cytochrome P450 14α-demethylase. Antimicrob Agents Chemother. 2003;47(2):577–81.PubMedPubMedCentralCrossRefGoogle Scholar
  26. 26.
    Camps SMT, Van Der Linden JWM, Li Y, Kuijper EJ, Van Dissel JT, Verweij PE, et al. Rapid induction of multiple resistance mechanisms in Aspergillus fumigatus during azole therapy: a case study and review of the literature. Antimicrob Agents Chemother. 2012;56(1):10–6.PubMedPubMedCentralCrossRefGoogle Scholar
  27. 27.
    Price TD, Qvarnström A, Irwin DE. The role of phenotypic plasticity in driving genetic evolution. Proc R Soc B Biol Sci. 2003;270(1523):1433–40.CrossRefGoogle Scholar
  28. 28.
    Paul S, Moye-Rowley WS. Multidrug resistance in fungi: regulation of transporter-encoding gene expression. Front Physiol. 2014;5:143.PubMedPubMedCentralCrossRefGoogle Scholar
  29. 29.
    Singh A, Mahto KK, Prasad R. Lipidomics and in Vitro azole resistance in Candida albicans. Omi A J Integr Biol. 2013;17(2):84–93.CrossRefGoogle Scholar
  30. 30.
    Brown AJP, Budge S, Kaloriti D, Tillmann A, Jacobsen MD, Yin Z, et al. Stress adaptation in a pathogenic fungus. J Exp Biol. 2014;217(1):144–55.PubMedPubMedCentralCrossRefGoogle Scholar
  31. 31.
    Hagiwara D, Sakamoto K, Abe K, Gomi K. Signaling pathways for stress responses and adaptation in Aspergillus species: stress biology in the post-genomic era. Biosci Biotechnol Biochem. 2016;80(9):1667–80.PubMedCrossRefGoogle Scholar
  32. 32.
    Nierman WC, Pain A, Anderson MJ, Wortman JR, Kim HS, Arroyo J, et al. Genomic sequence of the pathogenic and allergenic filamentous fungus Aspergillus fumigatus. Nature. 2005;438(7071):1151–6.PubMedCrossRefGoogle Scholar
  33. 33.
    Supek F, Bošnjak M, Škunca N, Šmuc T. Revigo summarizes and visualizes long lists of gene ontology terms. PLoS One. 2011;6(7):e21800.PubMedPubMedCentralCrossRefGoogle Scholar
  34. 34.
    Hong G, Zhang W, Li H, Shen X, Guo Z. Separate enrichment analysis of pathways for up- and downregulated genes. J R Soc Interface. 2013;11(92):20130950.PubMedCrossRefGoogle Scholar
  35. 35.
    König CC, Scherlach K, Schroeckh V, Horn F, Nietzsche S, Brakhage AA, et al. Bacterium induces cryptic meroterpenoid pathway in the pathogenic fungus Aspergillus fumigatus. Chembiochem. 2013;14(8):938–42.PubMedCrossRefGoogle Scholar
  36. 36.
    Chooi YH, Fang J, Liu H, Filler SG, Wang P, Tang Y. Genome mining of a prenylated and immunosuppressive polyketide from pathogenic fungi. Org Lett. 2013;15(4):780–3.PubMedPubMedCentralCrossRefGoogle Scholar
  37. 37.
    Perlin MH, Andrews J, Toh SS. Essential letters in the fungal alphabet: ABC and MFS transporters and their roles in survival and pathogenicity. Adv Genet. 2014;85:201–53 Elsevier.Google Scholar
  38. 38.
    Paul S, Diekema D, Moye-Rowley WS. Contributions of Aspergillus fumigatus ATP-binding cassette transporter proteins to drug resistance and virulence. Eukaryot Cell. 2013;12(12):1619–28.PubMedPubMedCentralCrossRefGoogle Scholar
  39. 39.
    Paul S, Diekema D, Moye-Rowley WS. Contributions of both ATP-binding cassette transporter and Cyp51A proteins are essential for azole resistance in Aspergillus fumigatus. Antimicrob Agents Chemother. 2017;61(5):e02748-16.Google Scholar
  40. 40.
    Sgherri C, Porta A, Castellano S, Pinzino C, Quartacci MF, Calucci L. Effects of azole treatments on the physical properties of Candida albicans plasma membrane: A spin probe EPR study. Biochim Biophys Acta - Biomembr. 2014;1838(1 PARTB):465–73.CrossRefGoogle Scholar
  41. 41.
    Do JH, Lim BO, Choi WS, Choi DK. Exploring the phospholipid biosynthetic pathways of Aspergillus fumigatus by computational genome analysis. Eng Life Sci. 2005;5(6):574–9.CrossRefGoogle Scholar
  42. 42.
    Henry SA, Kohlwein SD, Carman GM. Metabolism and regulation of glycerolipids in the yeast Saccharomyces cerevisiae. Genetics. 2012;190(2):317–49.Google Scholar
  43. 43.
    Van Meer G, Voelker DR, Feigenson GW. Membrane lipids: where they are and how they behave. Nat Rev Mol Cell Biol. 2008;9(2):112–24.PubMedPubMedCentralCrossRefGoogle Scholar
  44. 44.
    Martin CE, Oh C-S, Jiang Y. Regulation of long chain unsaturated fatty acid synthesis in yeast. Biochim Biophys Acta. 2007;1771(3):271–85.PubMedCrossRefPubMedCentralGoogle Scholar
  45. 45.
    Renne MF, de Kroon AIPM. The role of phospholipid molecular species in determining the physical properties of yeast membranes. FEBS Lett. 2018;592(8):1330–45.PubMedCrossRefPubMedCentralGoogle Scholar
  46. 46.
    Cowen LE, Sanglard D, Howard SJ, Rogers PD, Perlin DS. Mechanisms of antifungal drug resistance. Cold Spring Harb Perspect Med. 2014;5(7):a019752.PubMedCrossRefPubMedCentralGoogle Scholar
  47. 47.
    Takahashi H, Kusuya Y, Hagiwara D, Takahashi-Nakaguchi A, Sakai K, Gonoi T. Global gene expression reveals stress-responsive genes in Aspergillus fumigatus mycelia. BMC Genomics. 2017;18(1):1–15.CrossRefGoogle Scholar
  48. 48.
    Dirr F, Echtenacher B, Heesemann J, Hoffmann P, Ebel F, Wagener J. AfMkk2 is required for cell wall integrity signaling, adhesion, and full virulence of the human pathogen Aspergillus fumigatus. Int J Med Microbiol. 2010;300(7):496–502.PubMedCrossRefPubMedCentralGoogle Scholar
  49. 49.
    Lockshon D, Olsen CP, Brett CL, Chertov A, Merz AJ, Lorenz DA, et al. Rho signaling participates in membrane fluidity homeostasis. PLoS One. 2012;7(10):1–10.CrossRefGoogle Scholar
  50. 50.
    Ma D, Li R. Current understanding of HOG-MAPK pathway in Aspergillus fumigatus. Mycopathologia. 2013;175(1–2):13–23.PubMedCrossRefPubMedCentralGoogle Scholar
  51. 51.
    Reyes G, Romans A, Nguyen CK, May GS. Novel mitogen-activated protein kinase MpkC of Aspergillus fumigatus is required for utilization of polyalcohol sugars. Eukaryot Cell. 2006;5(11):1934–40.PubMedPubMedCentralCrossRefGoogle Scholar
  52. 52.
    Miskei M, Karányi Z, Pócsi I. Annotation of stress-response proteins in the aspergilli. Fungal Genet Biol. 2009;46(Suppl 1):S105–20.PubMedCrossRefPubMedCentralGoogle Scholar
  53. 53.
    Fillinger S, Ruijter G, Tamas MJ, Visser J, Thevelein JM, D’Enfert C. Molecular and physiological characterization of the NAD-dependent glycerol 3-phosphate dehydrogenase in the filamentous fungus Aspergillus nidulans. Mol Microbiol. 2001;39(1):145–57.PubMedCrossRefPubMedCentralGoogle Scholar
  54. 54.
    da Silva Ferreira ME, Malavazi I, Savoldi M, Brakhage AA, Goldman MHS, Kim HS, et al. Transcriptome analysis of Aspergillus fumigatus exposed to voriconazole. Curr Genet. 2006;50(1):32–44.PubMedCrossRefPubMedCentralGoogle Scholar
  55. 55.
    de Castro PA, Chen C, de Almeida RSC, Freitas FZ, Bertolini MC, Morais ER, et al. ChIP-seq reveals a role for CrzA in the Aspergillus fumigatus high-osmolarity glycerol response (HOG) signalling pathway. Mol Microbiol. 2014;94(3):655–74.PubMedCrossRefPubMedCentralGoogle Scholar
  56. 56.
    Meletiadis J, Meis JFGM, Mouton JW. Analysis of growth characteristics of filamentous fungi in different nutrient media. J Clin Microbiol. 2001;39(2):478–84.PubMedPubMedCentralCrossRefGoogle Scholar
  57. 57.
    Ghannoum MA, Rice LB. Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance. ClinMicrobiolRev. 1999;12:501–17.Google Scholar
  58. 58.
    Fanning S, Mitchell AP. Fungal biofilms. PLoS Pathog. 2012;8(4):1–4.CrossRefGoogle Scholar
  59. 59.
    Müller FMC, Seidler M, Beauvais A. Aspergillus fumigatus biofilms in the clinical setting. Med Mycol. 2011;49(SUPPL. 1):96–100.CrossRefGoogle Scholar
  60. 60.
    Alp S, Arikan S. Investigation of extracellular elastase, acid proteinase and phospholipase activities as putative virulence factors in clinical isolates of Aspergillus species. J Basic Microbiol. 2008;48(5):331–7.PubMedCrossRefPubMedCentralGoogle Scholar
  61. 61.
    Okumura Y, Matsui T, Ogawa K, Uchiya K, Nikai T. Biochemical properties and primary strucutre of elastase inhibitor AFUEI from Aspergillus fumigatus. J Med Microbiol. 2008;57(Pt 7):803–8.PubMedCrossRefPubMedCentralGoogle Scholar
  62. 62.
    Cascón A, Yugueros J, Temprano A, Sánchez M, Hernanz C, Luengo JM, et al. A major secreted elastase is essential for pathogenicity of Aeromonas hydrophila. Infect Immun. 2000;68(6):3233–41.PubMedPubMedCentralCrossRefGoogle Scholar
  63. 63.
    Tamura Y, Suzuki S, Sawada T. Role of elastase as a virulence factor in experimental Pseudomonas aeruginosa Infection in Mice. Microb Pathog. 1992;12(3):237–44.PubMedCrossRefPubMedCentralGoogle Scholar
  64. 64.
    Manente M, Ghislain M. The lipid-translocating exporter family and membrane phospholipid homeostasis in yeast. FEMS Yeast Res. 2009;9(5):673–87.PubMedCrossRefPubMedCentralGoogle Scholar
  65. 65.
    Blatzer M, Barker BM, Willger SD, Beckmann N, Blosser SJ, Cornish EJ, et al. SREBP coordinates iron and ergosterol homeostasis to mediate triazole drug and hypoxia responses in the human fungal pathogen Aspergillus fumigatus. PLoS Genet. 2011;7(12):e1002374.PubMedPubMedCentralCrossRefGoogle Scholar
  66. 66.
    Yasmin S, Alcazar-Fuoli L, Grundlinger M, Puempel T, Cairns T, Blatzer M, et al. Mevalonate governs interdependency of ergosterol and siderophore biosyntheses in the fungal pathogen Aspergillus fumigatus. Proc Natl Acad Sci. 2012;109(8):E497–504.PubMedCrossRefPubMedCentralGoogle Scholar
  67. 67.
    Rajendran R, Mowat E, McCulloch E, Lappin DF, Jones B, Lang S, et al. Azole resistance of Aspergillus fumigatus biofilms is partly associated with efflux pump activity. Antimicrob Agents Chemother. 2011;55(5):2092–7.PubMedPubMedCentralCrossRefGoogle Scholar
  68. 68.
    Fraczek MG, Bromley M, Buied A, Moore CB, Rajendran R, Rautemaa R, et al. The cdr1B efflux transporter is associated with non-cyp51a-mediated itraconazole resistance in Aspergillus fumigatus. J Antimicrob Chemother. 2013;68(7):1486–96.PubMedCrossRefPubMedCentralGoogle Scholar
  69. 69.
    Vale-Silva LA, Coste AT, Ischer F, Parker JE, Kelly SL, Pinto E, et al. Azole resistance by loss of function of the sterol Δ5,6- desaturase gene (ERG3) in Candida albicans does not necessarily decrease virulence. Antimicrob Agents Chemother. 2012;56(4):1960–8.PubMedPubMedCentralCrossRefGoogle Scholar
  70. 70.
    Alcazar-Fuoli L, Mellado E, Garcia-Effron G, Lopez JF, Grimalt JO, Cuenca-Estrella JM, et al. Ergosterol biosynthesis pathway in Aspergillus fumigatus. Steroids. 2008;73(3):339–47.PubMedCrossRefPubMedCentralGoogle Scholar
  71. 71.
    Alcazar-Fuoli L, Mellado E. Ergosterol biosynthesis in Aspergillus fumigatus: its relevance as an antifungal target and role in antifungal drug resistance. Front Microbiol. 2012;3:1–6.Google Scholar
  72. 72.
    Nes WD, Xu S, Haddon WF. Evidence for similarities and differences in the biosynthesis of fungal sterols. Steroids. 1989;53(3–5):533–58.PubMedCrossRefPubMedCentralGoogle Scholar
  73. 73.
    Dawaliby R, Trubbia C, Delporte C, Noyon C, Ruysschaert JM, Van Antwerpen P, et al. Phosphatidylethanolamine is a key regulator of membrane fluidity in eukaryotic cells. J Biol Chem. 2016;291(7):3658–67.PubMedCrossRefPubMedCentralGoogle Scholar
  74. 74.
    Ballweg S, Ernst R. Control of membrane fluidity: the OLE pathway in focus. Biol Chem. 2017;398(2):215–28.PubMedCrossRefPubMedCentralGoogle Scholar
  75. 75.
    Fujioka T, Mizutani O, Furukawa K, Sato N, Yoshimi A, Yamagata Y, et al. MpkA-dependent and -independent cell wall integrity signaling in Aspergillus nidulans. Eukaryot Cell. 2007;6(8):1497–510.PubMedPubMedCentralCrossRefGoogle Scholar
  76. 76.
    Brown NA, Goldman GH. The contribution of Aspergillus fumigatus stress responses to virulence and antifungal resistance. J Microbiol. 2016;54(3):243–53.PubMedCrossRefGoogle Scholar
  77. 77.
    Liu FF, Pu L, Zheng QQ, Zhang YW, Gao RS, Xu XS, et al. Calcium signaling mediates antifungal activity of triazole drugs in the Aspergilli. Fungal Genet Biol. 2014;81:182–90.PubMedCrossRefPubMedCentralGoogle Scholar
  78. 78.
    Jun SC, Lee SJ, Park HJ, Kang JY, Leem YE, Yang TH, et al. The MpkB MAP kinase plays a role in post-karyogamy processes as well as in hyphal anastomosis during sexual development in Aspergillus nidulans. J Microbiol. 2011;49(3):418–30.PubMedCrossRefGoogle Scholar
  79. 79.
    Elion E a, Satterberg B, Kranz JE. FUS3 phosphorylates multiple components of the mating signal transduction cascade: evidence for STE12 and FAR1. Mol Biol Cell. 1993;4(5):495–510.PubMedPubMedCentralCrossRefGoogle Scholar
  80. 80.
    Kim JH, Chan KL, Faria NCG. Martins M de L, Campbell BC. Targeting the oxidative stress response system of fungi with redox-potent chemosensitizing agents. Front Microbiol. 2012;3(MAR):1–11.Google Scholar
  81. 81.
    Avruch J. MAP kinase pathways: the first twenty years. Biochim Biophys Acta - Mol Cell Res. 2007;1773(8):1150–60.CrossRefGoogle Scholar
  82. 82.
    Kroll K, Pähtz V, Hillmann F, Vaknin Y, Schmidt-Heck W, Roth M, et al. Identification of hypoxia-inducible target genes of Aspergillus fumigatus by transcriptome analysis reveals cellular respiration as an important contributor to hypoxic survival. Eukaryot Cell. 2014;13(9):1241–53.PubMedPubMedCentralCrossRefGoogle Scholar
  83. 83.
    Cowen LE. Hsp90 potentiates the rapid evolution of new traits: drug resistance in diverse fungi. Science. 2015;309(5744):1–6.Google Scholar
  84. 84.
    Paul S, Moye-Rowley WS. Functional analysis of an ATP-binding cassette transporter protein from Aspergillus fumigatus by heterologous expression in Saccharomyces cerevisiae. Fungal Genet Biol. 2013;57:85–91.PubMedPubMedCentralCrossRefGoogle Scholar
  85. 85.
    Radhakrishnan A, Ikeda Y, Kwon HJ, Brown MS, Goldstein JL. Sterol-regulated transport of SREBPs from endoplasmic reticulum to Golgi: Oxysterols block transport by binding to Insig. Proc Natl Acad Sci. 2007;104(16):6511–8.PubMedCrossRefPubMedCentralGoogle Scholar
  86. 86.
    Baltussen TJH, Coolen JPM, Zoll J, Verweij PE, Melchers WJG. Gene co-expression analysis identifies gene clusters associated with isotropic and polarized growth in Aspergillus fumigatus conidia. Fungal Genet Biol. 2018;116:62–72.PubMedCrossRefPubMedCentralGoogle Scholar
  87. 87.
    Irmer H, Tarazona S, Sasse C, Olbermann P, Loeffler J, Krappmann S, et al. RNAseq analysis of Aspergillus fumigatus in blood reveals a just wait and see resting stage behavior. BMC Genomics. 2015;16(1):640.PubMedPubMedCentralCrossRefGoogle Scholar
  88. 88.
    Daly P, van Munster JM, Blythe MJ, Ibbett R, Kokolski M, Gaddipati S, et al. Expression of Aspergillus niger CAZymes is determined by compositional changes in wheat straw generated by hydrothermal or ionic liquid pretreatments. Biotechnol Biofuels. 2017;10(1):35.PubMedPubMedCentralCrossRefGoogle Scholar
  89. 89.
    Pontecorvo G, Roper JA, Chemmons LM, Macdonald KD, Bufton AWJ. The genetics of Aspergillus nidulans. Adv Genet. 1953;5(C):141–238.PubMedCrossRefPubMedCentralGoogle Scholar
  90. 90.
    Hill TW, Kafer E. Improved protocols for Aspergillus minimal medium: trace element and minimal medium salt stock solutions. Fungal Genet Rep. 2001;48(1):20–1.CrossRefGoogle Scholar
  91. 91.
    Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: Ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29(1):15–21.PubMedCrossRefPubMedCentralGoogle Scholar
  92. 92.
    Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):1–21.CrossRefGoogle Scholar
  93. 93.
    Cerqueira GC, Arnaud MB, Inglis DO, Skrzypek MS, Binkley G, Simison M, et al. The Aspergillus genome database: multispecies curation and incorporation of RNA-Seq data to improve structural gene annotations. Nucleic Acids Res. 2014;42(D1):705–10.CrossRefGoogle Scholar
  94. 94.
    Rao X, Lai D, Huang X. A new method for quantitative real-time polymerase chain reaction data analysis. J Comput Biol. 2013;20(9):703–11.PubMedPubMedCentralCrossRefGoogle Scholar

Copyright information

© The Author(s). 2019

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors and Affiliations

  • Margriet W. J. Hokken
    • 1
    • 2
    Email author
  • Jan Zoll
    • 1
    • 2
  • Jordy P. M. Coolen
    • 1
    • 2
  • Bas J. Zwaan
    • 3
  • Paul E. Verweij
    • 1
    • 2
  • Willem J. G. Melchers
    • 1
    • 2
  1. 1.Department of Medical MicrobiologyRadboud University Medical CenterNijmegenthe Netherlands
  2. 2.Center of Expertise in Mycology Radboudumc/CWZNijmegenthe Netherlands
  3. 3.Department of Plant Sciences, Laboratory of GeneticsWageningen UniversityWageningenThe Netherlands

Personalised recommendations